Effectiveness of a Transdiagnostic Internet-based Treatment for Emotional Disorders

NCT02345668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-09-24

No results posted yet for this study

Summary

The aim of this study is to assess the efficacy of a Transdiagnostic Internet-based Protocol (Emotion Regulation Protocol) for the treatment of unipolar mood disorders (major depression and dysthimia) four anxiety disorders (Panic disorder, agoraphobia, generalized anxiety disorder and social anxiety disorder) and obsessive-compulsive disorder in comparison with Treatment as Usual in specialized care (Spanish public mental health system).

Conditions

Interventions

BEHAVIORAL

Emotion Regulation Protocol

Emotion Regulation Protocol is an Internet-based Self-administered Protocol for emotional disorders, which will allow the individual to learn and practice adaptive ways to regulate their emotions from a transdiagnostic perspective. The protocol contains the following components: present-focused emotional awareness, cognitive flexibility, emotional avoidance and emotion-driven behaviors, interoceptive and situation-based emotion exposure, psychoeducation about emotions, motivational enhancement and relapse prevention, which are organized in twelve modules: Emotional disorders and emotion regulation; Motivation for change; Understanding the role of emotions; The acceptance of emotional experiences; Practicing the acceptance; Learning to be flexible; Practicing the cognitive flexibility; The emotional avoidance; Emotion driven behaviors; Accepting and facing physical sensations; Facing emotions in the contexts in which they occur; and Relapse Prevention.

DRUG

Treatment as Usual (Pharmacological Treatment)

The Pharmacological Treatment provided by a psychiatrist in the mental health unit.

BEHAVIORAL

Treatment as Usual (Psychological Treatment)

The Psychological Treatment provided by a clinical psychologist in the mental health unit.

Sponsors & Collaborators

  • Consorcio Hospitalario Provincial de Castellón

    collaborator UNKNOWN
  • Universitat Jaume I

    lead OTHER

Principal Investigators

  • Cristina Botella, Professor · University Jaume I, Castellon, Spain

  • Azucena García-Palacios, Professor · University Jaume I, Castellon, Spain

  • Francisco Traver · Consorcio Hospitalario Provincial de Castellón, Spain

  • Gonzalo Haro · Consorcio Hospitalario Provincial de Castellón, Spain

  • Ginés Llorca · Consorcio Hospitalario Provincial de Castellón, Spain

  • Alberto Gonzalez-Robles, PhD Student · University Jaume I, Castellon, Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02345668 on ClinicalTrials.gov